TheEdgeResearch
Home / Stocks / PAIOF

Paion AG (PAIOF)

OTC Healthcare Medical - Pharmaceuticals
$0.05 ▲ +0.00%
Market Cap
$410,188
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Beta
4.14
52-Wk Range
0.01-0.07
CEO
Jay Pestrichelli
Country
DE
Currency
USD

Paion AG operates in the Medical - Pharmaceuticals industry of the Healthcare sector, headquartered in Aachen, NW, DE. The stock last traded at $0.05, up 0.00% on the session, giving a market capitalisation of $410,188. On trailing twelve-month figures it carries a trailing P/E of -0.56, a net margin of -1.7%. Its beta of 4.14 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
-0.56
Price / Sales
0.01
Price / Book
0.00
EV / EBITDA
0.07
Gross margin
94.1%
Operating margin
4.5%
Net margin
-1.7%
Return on equity
—
Debt / equity
0.00
Current ratio
0.00
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
64
IPO date
2009-09-28
Headquarters
Aachen, NW, DE
About Paion AG

Paion AG operates as a specialized pharmaceutical entity, concentrating its efforts on creating and selling groundbreaking treatments within the realms of anesthesia, intensive care, and critical care medicine. The company places particular importance on quickly-acting sedatives and other hospital-specific items.

Comparable companies

Paion AG is most often compared with the following Healthcare names:

CATVCNTRFCSUICTTHELLXFIDCNNGMCNPHCORGSPHCG
More research on PAIOF
PAIOF technical analysis PAIOF TheEdge Score Compare against peers
Open full interactive analysis & DCF →